Table 1.
Demographic details and laboratory findings of T2DM and NDM patients infected with SARS-CoV2.
| T2DM n = 25 |
NDM n = 10 |
P value | |
|---|---|---|---|
| Age, median (IQR), years | 46 (36-59) | 49 (40.25-55.50) | N. A |
| Sex, man/woman, n (%) | 17 (68%)/8 (32%) | 7 (70%)/3 (10%) | N. A |
| Hemoglobin, gm/dl median (IQR) | 12.2 (11.35-13.60) | 14.25 (13.7-14.9) | 0.0475 |
| Platelets 103/µL median (IQR) | 193 (154.5-235) | 165 (159.5-197.5) | 0.4027 |
| White blood cells 103/µL, median (IQR) | 6.1 (5.00-57.65) | 5.8 (5.2-5.575) | 0.4172 |
| Neutrophils %, median (IQR) | 75 (65.5-84) | 55 (44.75-62) | 0.0004 |
| Lymphocytes %, median (IQR) | 22 (15.5-29.75) | 36 (26.75-39.75) | 0.0349 |
| Eosinophils %, median (IQR) | 0 | 3 (3-4.5) | <0.0001 |
| Monocytes %, median (IQR) | 7 (5-9) | 9 (8.5-10) | 0.0373 |
| D-dimer µg/mL, median (IQR) | 0.45 (0.29-1.61) | 0.19 (0.15-0.25) | 0.0048 |
| Ferritin ng/mL, median (IQR) | 224.7 (145.9-464.1) | 115 (110-289.5) | 0.4975 |
| Fasting plasma glucose mg/dL, median (IQR) | 215 (142.72-244) | 95.5 (88-101) | <0.0001 |
| Hb1AC %, median (IQR) | 6.9 (6-9) | N. T | N. A |
| CRP mg/mL, median (IQR) | 69.62 (34.95-211) | 13.28 (4.44-18.65) | 0.0013 |
| Serum SGOT U/L, median (IQR) | 46.9 (30.2-64.6) | 38 (30.75-43.25) | 0.4432 |
| Serum SGPT U/L, median (IQR) | 27.6 (20-42) | 40.5 (24.5-76.5) | 0.1335 |
Hb1AC, glycated hemoglobin; CRP, C-reactive protein; Serum SGOT, serum glutamic-oxaloacetic transaminase; Serum SGPT, serum glutamic-pyruvic transaminase; N.T., not tested; N.A., not applicable.